Work

Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01)

Year: 2020

Type: article

Study design: Observational Study

Source: Annals of Surgical Oncology

DOI: 10.1245/s10434-019-07846-2

Authors: T. J. Stankowski-Drengler, J. R. Schumacher, B. Hanlon, D. Livingston-Rosanoff, K. Van de Walle, C. C. Greenberg, L. G. Wilke, H. B. Neuman

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Patient-Centered Outcomes Research Institute, National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: G115506582, G1300295635, Clinical Academic Oncologist Training Program, G3769056820, G661093285, G665638586, University of Wisconsin Institute for Clinical and Translational Research

OpenAlex ID: W2997259335

FWCI: 0.169

Cites: 31

Cited by: 3

Related to: 10